Search
Displaying results 601 to 609 of 609.
Equipment and materials management specialist (m/f/d)
The Purchasing and Materials Management department is looking for clerical support as soon as possible.
Paths into the unknown
EM started in 1982 at the former Gesellschaft für Biotechnologische Forschung (GBF) and in 1989 moved into a new building, which presented a major challenge in itself: The floors of the new building were covered with vibrating screed, which is not suitable for…
Buyer / Administrator Purchasing, Equipment and Materials Management (m/f/d)
The Purchasing and Materials Management department is looking for a Buyer / Administrator to start as soon as possible.
Hair follicle models from the 3D printer
Hair follicles are complex structures that surround the hair root, anchoring it to the skin and giving the hair its hold. At the same time, the area between the skin and the follicle provides optimal conditions for microorganisms to multiply unhindered. This often leads…
Making sense of the data jungle
Antibiotic resistance is rising worldwide and poses a major challenge to healthcare systems. Understanding the underlying processes of how and why some bacteria develop such defenses is critical. Differences in bacterial gene expression—in which the information in a…
Doctoral Researcher (f/m/d) – "Deciphering host-pathogen interactions in the context of immune signaling"
The Department of Cellular Immune Signalling is looking for a PhD student.
Leendertz: "Human health cannot be viewed in isolation"
Contact between humans and animals is becoming increasingly closer. This is due to the growing world population, the ever deeper intrusion of humans into natural habitats, the hunting of wildlife, and intensive livestock farming and agriculture. Combined with…
New vector vaccine against COVID-19 provides long-term protection
In 2022, researchers from the department “Viral Immunology” headed by Prof. Luka Cicin-Sain at the Helmholtz Centre for Infection Research reported on the novel vector vaccine for the first time. The promising immunogenic profile of the MCMV-based vaccine has now been…
